Scienture announces U.S. FDA approval of NDA for SCN-102
Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...
Nasdaq Down Over 400 Points; Kroger Posts Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 400 points on Thursday. The Dow ...
What's Going On With Scienture Stock Thursday?
Scienture Holdings, Inc. SCNX stock is trading higher on Thursday after the company partnered with Kindeva to launch REZENOPY ...
The Manila Times12d
Green Lawn Augusta Expands Premier Lawn Care & Landscaping Services in Augusta, Evans, and Grovetown, GA
Green Lawn Augusta is a locally owned and operated lawn care and landscaping company serving Augusta, Evans, and Grovetown, ...
Scienture to commercially launch REZENOPY through Kindeva collaboration
HOLDINGS announce that its wholly owned subsidiary, Scienture has entered into a definitive agreement with SUMMIT BIOSCIENCES, ...
SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.
SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...